HTBA to unveil GLP-1 support ingredient for muscle health and energy at Vitafoods Europe 2026
HTBA (HealthTech Bio Actives) will unveil a new GLP-1 companion ingredient at the upcoming Vitafoods Europe 2026 trade show (May 5–7). The dual-effect ingredient, Leanara, supports muscle mass and...
Cargill showcases nutrition concepts to support active lifestyles at Vitafoods Europe 2026
At the upcoming Vitafoods Europe 2026 trade show (May 5–7), Cargill will highlight how active nutrition is expanding beyond sports performance to address broader health trends, such as gut health,...
Infusd Nutrition’s emulsion tech enables functional food formats with non-soluble ingredients
Amid ongoing consumer “pill fatigue,” the nutrition industry is exploring new formats to meet demands for fun and convenient formats, such as gummies and functional foods or beverages. However, it is...
Symrise invests in Bond Pet Foods for sustainable innovation in biotechnology
Symrise has made an equity investment in Bond Pet Foods to complement its pet nutrition portfolio. The US biotechnology company produces animal-identical proteins with precision fermentation. Symrise...
Paul Stamets explores mycology and immune health benefits of mushroom mycelium
In the growing mushroom supplements industry, there is an increased focus on mycelium’s impact on immunity and other health benefits. This root-like network of fungi consists of thread-like branches...
TopGum to unveil new women’s health gummies at Vitafoods Europe 2026
TopGum Industries has launched a new line of women’s health gummy infusions with seven formulations that cater to consumers’ needs throughout “every phase of life,” from teens to women in menopause....
Key trends shaping health and wellness acquisitions & growth in nutrition industry
The nutrition industry is experiencing significant consolidations, driven by strong consumer demand for health and wellness solutions. H&H Group, an international health and nutrition company, says...
Evanium raises seed funding for technology boosting supplement bioavailability
Evanium has secured €2.2 million (US$2.6 million) in seed funding to scale its proprietary Optisolv technology, which it says can solve the “bioavailability crisis” behind ineffective...
